Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Passey · SciRah

Researcher profile · Semantic Scholar

C. Passey

Share profile

C. Passey — researcher profile on SciRah

h-index: 10
Works: 24
Citations: 431

Most-cited papers

Dosing equation for tacrolimus using genetic variants and clinical factors.
C. Passey, A. Birnbaum, R. Brundage, W. Oetting +2 more
2011British Journal of Clinical Pharmacology188 citations Open access
Semantic Scholar
Validation of tacrolimus equation to predict troughs using genetic and clinical factors
C. Passey, A. Birnbaum, R. Brundage, D. Schladt +6 more
2012Pharmacogenomics (London)39 citations Open access
Semantic Scholar
Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myeloma
L. Gibiansky, C. Passey, A. Roy, A. Bello +1 more
2016Journal of Pharmacokinetics and Pharmacodynamics35 citations
Semantic Scholar
Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study
K. Yonemori, Y. Kuboki, K. Hasegawa, T. Iwata +11 more
2022Cancer Science30 citations Open access
Semantic Scholar
Methods for determining key components in a mathematical model for tumor-immune dynamics in multiple myeloma.
J. Gallaher, K. Larripa, Marissa Renardy, Blerta Shtylla +10 more
2018Journal of Theoretical Biology22 citations
Semantic Scholar
Population pharmacokinetic analysis for tisotumab vedotin in patients with locally advanced and/or metastatic solid tumors
L. Gibiansky, C. Passey, J. Voellinger, R. Gunawan +3 more
2022CPT: Pharmacometrics & Systems Pharmacology18 citations Open access
Semantic Scholar
Reporting, Visualization, and Modeling of Immunogenicity Data to Assess Its Impact on Pharmacokinetics, Efficacy, and Safety of Monoclonal Antibodies
C. Passey, S. Suryawanshi, Kinjal Sanghavi, M. Gupta
2018AAPS Journal17 citations
Semantic Scholar
Exposure‐safety and exposure‐efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors
C. Passey, J. Voellinger, L. Gibiansky, R. Gunawan +5 more
2023CPT: Pharmacometrics & Systems Pharmacology15 citations Open access
Semantic Scholar
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts
Sonja Althammer, K. Steele, M. Rebelatto, Tze-Heng Tan +431 more
2016Journal for ImmunoTherapy of Cancer15 citations Open access
Semantic Scholar
Osteoarthritis disease progression model using six year follow‐up data from the osteoarthritis initiative
C. Passey, Holly Kimko, P. Nandy, L. Kagan
2015Journal of clinical pharmacology11 citations
Semantic Scholar
An Integrated Assessment of the Effects of Immunogenicity on the Pharmacokinetics, Safety, and Efficacy of Elotuzumab
C. Passey, J. Mora, R. Dodge, L. Gibiansky +4 more
2017AAPS Journal10 citations
Semantic Scholar
Safety of the natural killer (NK) cell-targeted anti-KIR antibody, lirilumab (liri), in combination with nivolumab (nivo) or ipilimumab (ipi) in two phase 1 studies in advanced refractory solid tumors
N. Segal, J. Infante, R. Sanborn, G. Gibney +16 more
20169 citations Open access
Semantic Scholar
The Clinical Pharmacology of Elotuzumab
C. Passey, J. Sheng, J. Mora, A. Tendolkar +5 more
2018Clinical Pharmacokinetics8 citations
Semantic Scholar
Effects of elotuzumab on QT interval and cardiac safety in patients with multiple myeloma
C. Passey, R. Darbenzio, Ying-Ming Jou, M. Lynch +1 more
2016Cancer Chemotherapy and Pharmacology6 citations
Semantic Scholar
A Mathematical Model for Tumor–Immune Dynamics in Multiple Myeloma
J. Gallaher, K. Larripa, U. Ledzewicz, Marissa Renardy +11 more
20184 citations
Semantic Scholar
Exposure-safety Markov modeling of ocular adverse events in patient populations treated with tisotumab vedotin
Summer Feng, R. Gunawan, C. Passey, Jenna Voellinger +7 more
2025Journal of Pharmacokinetics and Pharmacodynamics2 citations Open access
Semantic Scholar
Is relief from diabetes just a breath away?
C. Passey, S. Bhardwaj, D. Majumdar
2009Current Drug Delivery2 citations
Semantic Scholar
5P Tisotumab vedotin (TV) dose schedule optimization in non-cervical populations
J. Voellinger, C. Passey, Y.-S. Feng, R. Gunawan +8 more
2023ESMO Open1 citations Open access
Semantic Scholar
Predicting Tumor Growth Dynamics and Overall Survival with Deep Learning Model
Eric Song, Kashvi Srivastava, Kinjal Sanghavi, C. Le Gallo +2 more
2026Predicting Tumor Growth Dynamics and Overall Survival with Deep Learning Model0 citations Open access
Semantic Scholar
Mechanistic Drivers, Translational Gaps, and Modeling Approaches for Ocular Adverse Events in Antibody–Drug Conjugate Therapy
T. de Souza, Ping Peng, R. Gunawan, Jenna Voellinger +5 more
2026Journal of cancer immunology0 citations Open access
Semantic Scholar
Reporting, Visualization, and Modeling of Immunogenicity Data to Assess Its Impact on Pharmacokinetics, Efficacy, and Safety of Monoclonal Antibodies
C. Passey, S. Suryawanshi, Kinjal Sanghavi, M. Gupta
2018AAPS Journal0 citations
Semantic Scholar
Model-based pharmacokinetic analysis of elotuzumab in patients with relapsed/refractory multiple myeloma
L. Gibiansky, C. Passey, A. Roy, A. Bello +1 more
2016Journal of Pharmacokinetics and Pharmacodynamics0 citations
Semantic Scholar
Application of pharmacometrics for covariate selection and dose optimization of tacrolimus in adult kidney transplant recipients
C. Passey
20120 citations
Semantic Scholar
Application of Machine Learning Methods to Predict Risk of Adverse Events in Clinical Trials
Eric Song, C. Gallo, R. Gunawan, Jenna Voellinger +2 more
Proceedings of the American Conference of Pharmacometrics 20240 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Gibiansky×6
Invite
L. Gibiansky — researcher profile on SciRah
M. Gupta×6
Invite
M. Gupta — researcher profile on SciRah
R. Gunawan×5
Invite
R. Gunawan — researcher profile on SciRah
A. Roy×4
Invite
A. Roy — researcher profile on SciRah

×4

Invite

A. Bello — researcher profile on SciRah

Invite

R. Leidner — researcher profile on SciRah

Invite

Summer Feng — researcher profile on SciRah

Invite

L. Nicácio — researcher profile on SciRah

Invite

I. Soumaoro — researcher profile on SciRah

Michael D. Robbins×3

Invite

Michael D. Robbins — researcher profile on SciRah

J. Voellinger×3

Invite

J. Voellinger — researcher profile on SciRah

Kinjal Sanghavi×3

Invite

Kinjal Sanghavi — researcher profile on SciRah